Identification of Five Tumor Antigens for Development and Two Immune Subtypes for Personalized Medicine of mRNA Vaccines in Papillary Renal Cell Carcinoma
Increasing evidence has revealed the promise of mRNA-type cancer vaccines as a new direction for cancer immune treatment in several solid tumors, however, its application in papillary renal cell carcinoma (PRCC) remains unclear. The purpose of this study was to identify potential tumor antigens and...
Main Authors: | Jianpei Hu, Zhongze Yuan, Yifen Jiang, Zengnan Mo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/2/359 |
Similar Items
-
Dissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine
by: Jianpei Hu, et al.
Published: (2023-01-01) -
Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development
by: Zhuohui Chen, et al.
Published: (2022-07-01) -
An Update on the Treatment of Papillary Renal Cell Carcinoma
by: Neal S. Chawla, et al.
Published: (2023-01-01) -
Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancer
by: Lang Li, et al.
Published: (2023-09-01) -
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
by: Cong Liu, et al.
Published: (2022-01-01)